Laura Yecies is the CEO of Osteoboost Health, Inc., the company behind the first and only FDA-cleared, non-drug wearable for low bone density. She has over 30 years of leadership experience in the technology and medical sectors. Under her leadership, the company has secured $4.7 million in NIH grants, raised $15 million in private capital, acquired and integrated the digital health platform Wellen, and generated strong sales and clinical adoption for the Osteoboost device. She also oversaw the company’s nationwide launch in May 2025, bringing proactive bone health solutions to market at scale.
Why has there been so little progress against the rate of osteoporotic fractures and the associated morbidity and mortality? The deaths are real, the pain and suffering are real — and almost all of us have witnessed it. And, of course, the cost to our health system, $57 billion per year, is real.